01
June
The integrated anti-HCMV/anti-GBM vaccine
The integrated anti-HCMV/anti-GBM vaccine
Project title: The integrated anti-HCMV/anti-GBM vaccine
Program – Proof of concept for scientists is intended for financing ideas, concepts, prototypes and intellectual property protection. The emphasis is put on the technological risk, and the main criteria are market orientation and innovativeness.
Grantor: Croatian Agency for SMEs, Innovations and Investments (HAMAG-BICRO)
Grantor’s website: http://www.hamagbicro.hr/
Coordinator: Hrvoje Šimić, MD
Research team:
Suzana Malić, laboratory engineer
Prof. Dr. Stipan Jonjić
Assistant Professor Berislav Lisnić
Lea Hiršl, MA
Total funding (MEDRI): 349.776,99 HRK
Brief description:
Glioblastoma multiforme (GBM) represents the most malignant form of brain tumor. The overall survival prognosis is